麻豆女郎

Skip to Main Content
麻豆女郎

麻豆女郎 team earns patent for use of antioxidant compound

December 10, 2013
Jonathan Brestoff Parker 鈥08
Jonathan Brestoff Parker 鈥08

A 麻豆女郎 alumnus and professor have been awarded U.S. Patent No. 8,598,150 for use of an antioxidant compound that shows promise in the treatment of obesity and related disorders, such as type-2 diabetes.

The researchers鈥擩onathan R. Brestoff Parker, a 2008 graduate who is currently a trustee of the College, and Thomas H. Reynolds, associate professor of health and exercise sciences鈥攄iscovered that treating obese mice with an antioxidant called MnTBAP* decreases obesity and improves type-2 diabetes.

T.H. Reynolds
T.H. Reynolds

Obese mice that received the compound lost 40 percent of their body weight. 鈥淭o put that number in context, if a 300-pound obese person lost 40 percent of their body weight, they would have lost 120 pounds,鈥 said Brestoff Parker.

The compound works by breaking down triglycerides, which are stored in excess in fat tissue of obese people. The researchers鈥 next step, according to Reynolds, is 鈥渢o figure out how that happens. What are the cellular and molecular events that result in weight loss?鈥 He calls this stage of drug development 鈥渢he fun part of science鈥攖rying to design the next study that will yield information about how a biological system responds to a drug.鈥

Related News


Students+show+a+prototype+of+hockey+equipment+designed+for+female+players.+
The annual competition, endowed by Ken Freirich 鈥90, underscores 麻豆女郎鈥檚 commitment to fostering creativity, innovation, and entrepreneurship across disciplines.
Mar 5 2026

Meredith+Broussard+sits+at+a+classroom+desk%2C+smiling+and+gesturing+with+her+hands+as+she+speaks+to+students.
Artificial intelligence expert Meredith Broussard visited campus and challenged the Skidmore community to confront the ethical realities of AI.
Feb 24 2026

Melissa+Komora
Komora, who begins June 1, brings more than 25 years of philanthropy leadership to her new role as Collyer Vice President for Advancement.
Feb 19 2026